DEPARTMENT PROFILE

Hogan Lovells

Life Sciences (International Firms)

Band 3ChinaAsia-Pacific 2021 View ranking table
chambers review
department information
chambers review
department information

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

What the team is known for

Broad life science offering with expertise in IP, commercial agreements, business restructuring, M&A transactions, product liability and anti-corruption. Significant experience in handling regulatory matters relating to the growing fields of digital health and telemedicine. Retains a strong client base among pharmaceutical and medical device companies. Also has noteworthy expertise advising on clinical trials.

Strengths

Clients observe favourably that the team "provides prompt and succinct advice that considers legal requirements and business needs."

Notable practitioners

Wei Jun, chair of the Greater China practice, is the key contact.

Department Information

This content is provided by Hogan Lovells.

Overview

In this highly regulated, complex industry, clients need a legal advisor that truly understands the life sciences and healthcare sector. Hogan Lovells is one of very few practices that can offer this in China along with the ability to advise on the full scope of life sciences issues – from initial clinical trials to off-patent strategy, and from business development to defending complex
litigation.

They have a strong China regulatory practice and help their life sciences clients navigate complex regulatory hurdles. They have an incredibly strong regulatory practice comprising of partners who have previously worked in government and thus understand the ins and outs of the regulation. They also stay on top of innovation in the industry and how it is regulated such as wearable technology,
digital health, biosimilars and big data. 

They represent some of the biggest names in this sector. Globally, they have represented eight of the top 10 biotech companies, 19 of the top 20 pharmaceutical companies, and 29 of the top 30 medical devices companies in the world over the past year. These clients come to them because they are excellent at what they do and they trust the firm with their most business-critical and ground-breaking matters.

The team has strengths across all areas of law,including regulatory, pricing and reimbursement, commercial, IP and patent litigation, product liability as well as corporate/M&A and compliance and investigation.

Members

Wei, Jun

Zou, Roy

Clients

3M

Helsinn

JW Therapeutics (Shanghai) Co., Ltd.

Novartis

Sanofi

Starr Companies

University of Miami

Valeant Pharmaceuticals

Industries

Food & Drink Producers

Health Care

Pharmaceuticals & Life Sciences

Technology, Hardware & Electronics

Telecommunications

Life Sciences (International Firms) Department

Hogan Lovells

firm
Department location

11th Floor,

One Pacific Place,

88 Queensway,

Hong Kong

Hong Kong

China

View Firm Profile